886762-86-3

Basic information

• Product Name: 4-Bromo-3-fluorophenylene-1,2-diamine, 3,4-Diamino-2-fluorobromobenzene
• Synonyms: 4-Bromo-3-fluorobenzene-1,2-diamine;4-Bromo-3-fluorophenylene-1,2-diamine, 3,4-Diamino-2-fluorobromobenzene;4-broMo-3-fluorobenzene-1;4-Bromo-3-fluorobenzene-1,2-diamine 96%;4-Bromo-3-fluorophenylene-1,2-diamine, 1-Bromo-3,4-diamino-2-fluorobenzene;4-Bromo-3-fluorobenzene-1,2-diamine96%
• CAS NO: 886762-86-3
• Molecular Formula: C₆H₆BrFN₂
• Molecular Weight: 205.0276432
• Mol File: 886762-86-3.mol

Chemical Properties

• Boiling Point: 275.6±35.0 °C(Predicted)
• Appearance: /
• Density: 1.792±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C(protect from light)
• PKA: 2.44±0.10(Predicted)
• CAS DataBase Reference: 4-Bromo-3-fluorophenylene-1,2-diamine, 3,4-Diamino-2-fluorobromobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Bromo-3-fluorophenylene-1,2-diamine, 3,4-Diamino-2-fluorobromobenzene(886762-86-3)
• EPA Substance Registry System: 4-Bromo-3-fluorophenylene-1,2-diamine, 3,4-Diamino-2-fluorobromobenzene(886762-86-3)

Safety Data

• Hazardous Substances Data: 886762-86-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-Bromo-3-fluorophenylene-1,2-diamine is used as a key intermediate in the synthesis of pharmaceuticals and organic compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Dye and Pigment Industry:
3,4-Diamino-2-fluorobromobenzene is utilized in the production of dyes and pigments. Its distinct chemical properties contribute to the creation of vibrant colors and stable pigments for various applications.
Used in Organic Synthesis:
Both 4-Bromo-3-fluorophenylene-1,2-diamine and 3,4-Diamino-2-fluorobromobenzene are employed in organic synthesis as valuable building blocks. Their versatile structures enable the development of a wide range of organic compounds with diverse applications in various industries.

Upstream product

• 19064-24-5 2,6-difluoro-1-nitrobenzene 
• 886762-75-0 4-bromo-3-fluoro-2-nitro-phenylamine 

Downstream Products

• 1008361-72-5 5-bromo-4-fluoro-1H-benzo[d]imidazole 

Relevant articles and documents

Immunomodulator

The invention discloses an immunomodulator, and particularly relates to a compound for inhibiting IL-17A and application of the compound serving as the immunomodulator in preparation of drugs. The invention discloses application of a compound shown in a f

POLYCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND OR THE COMPOSITION

Specific polycyclic compounds, a material for an organic electroluminescence device comprising said specific polycyclic compound, an organic electroluminescence device comprising said specific polycyclic compound, an electronic equipment comprising said organic electroluminescence device, a process for preparing said polycyclic compounds, and the use of said polycyclic compounds in an organic electroluminescence. (Formula I) (I)

PYRIDIN-2-ONE DERIVATIVES OF FORMULA (II) USEFUL AS EP3 RECEPTOR ANTAGONISTS

The present invention is directed to pyridin-2-one derivatives, pharmaceutical compositions containing them and their use as antagonists of the EP3 receptor, for the treatment of for example, impaired oral glucose tolerance, elevated fasting glucose, Type II Diabetes Mellitus, Syndrome X (also known as Metabolic Syndrome) and related disorders and complications thereof.

PYRIDIN-2-ONE DERIVATIVES OF FORMULA (III) USEFUL AS EP3 RECEPTOR ANTAGONISTS

The present invention is directed to pyridin-2-one derivatives, pharmaceutical compositions containing them and their use as antagonists of the EP3 receptor, for the treatment of for example, impaired oral glucose tolerance, elevated fasting glucose, Type II Diabetes Mellitus, Syndrome X (also known as Metabolic Syndrome) and related disorders and complications thereof.

PYRIDIN-2-ONE DERIVATIVES OF FORMULA (I) USEFUL AS EP3 RECEPTOR ANTAGONISTS

The present invention is directed to pyridin-2-one derivatives, pharmaceutical compositions containing them and their use as antagonists of the EP3 receptor, for the treatment of for example, impaired oral glucose tolerance, elevated fasting glucose, Type II Diabetes Mellitus, Syndrome X (also known as Metabolic Syndrome) and related disorders and complications thereof.

SERINE/THREONINE PAK1 INHIBITORS

Compounds having the formula I wherein A, Z, R1a, R1b, R2, R3, R4, R5, R6, R7, R9, R10, Ra, Rb and n are as defined herein are inhibitors of PAK1. Also disclosed are compositions and methods for treating cancer and hyperproliferative disorders.

ANTI-VIRAL COMPOUNDS

Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS

This invention relates to novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy.